The Future of Biopharma

by David Gemmell | December 6, 2022

Lynx-CDR-connections-to-Bioreactor-and-Mixer,-M9933_150720_225

The Chemical Engineering magazine has published its third article of the biopharmaceutical manufacturing series, written by David Gemmell.

In the article “The Future of Biopharma” he explores why the biopharmaceutical industry is driving towards achieving intensified, connected, or continuous, manufacturing processes. He discusses the challenges that must be overcome to be able to operate a controllable process capable of providing high quality therapeutics.

Want to learn more about how the future of Biopharma could look like? Read the third article of the biopharmaceutical manufacturing series here: The Future of Biopharma.

[molongui_author_box]

Related Posts

Hiring Challenges in Bioprocessing for Start-ups

Creating Bottlenecks in Europe; Opportunities for Production Staff BioPlan Associates, Inc. Hiring of bioprocessing professionals has remained a…

When to sprint and when to breathe in the race from lab to clinic – 5 critical steps to success

As an early-stage or small-sized biotech company, you need to move fast and be nimble.  Success is measured…

Starting your journey into manufacturing – choosing a cell line development provider

One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …

A Streamlined Approach to Analytical Method Development and Implementation

The development and implementation of analytical methods are essential for success at all phases of a molecule’s journey,…

Scroll to Top